In the News
UC San Diego researchers have received a $3 million grant to find better therapies for triple-negative breast cancer, which is especially difficult to treat.
The grant was one of three announced Feb. 12 by the California Initiative to Advance Precision Medicine. It’s part of the Governor’s Office of Planning and Research.
This batch of grants goes to projects to reduce disparities in health care for Latinos and Latinas.
The UCSD grant focuses on genomic profiling to find new treatments and better match therapies to triple-negative cancers, which don’t respond to common genetically targeted cancer drugs. Latinas have a higher risk of triple-negative breast cancers.